1. Home
  2. ANVS vs MCHX Comparison

ANVS vs MCHX Comparison

Compare ANVS & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • MCHX
  • Stock Information
  • Founded
  • ANVS 2008
  • MCHX 2003
  • Country
  • ANVS United States
  • MCHX United States
  • Employees
  • ANVS N/A
  • MCHX N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • MCHX Business Services
  • Sector
  • ANVS Health Care
  • MCHX Consumer Discretionary
  • Exchange
  • ANVS Nasdaq
  • MCHX Nasdaq
  • Market Cap
  • ANVS 92.6M
  • MCHX 84.3M
  • IPO Year
  • ANVS 2020
  • MCHX 2004
  • Fundamental
  • Price
  • ANVS $2.95
  • MCHX $1.94
  • Analyst Decision
  • ANVS Strong Buy
  • MCHX
  • Analyst Count
  • ANVS 6
  • MCHX 0
  • Target Price
  • ANVS $29.67
  • MCHX N/A
  • AVG Volume (30 Days)
  • ANVS 548.9K
  • MCHX 26.5K
  • Earning Date
  • ANVS 03-31-2025
  • MCHX 03-13-2025
  • Dividend Yield
  • ANVS N/A
  • MCHX N/A
  • EPS Growth
  • ANVS N/A
  • MCHX N/A
  • EPS
  • ANVS N/A
  • MCHX N/A
  • Revenue
  • ANVS N/A
  • MCHX $48,594,000.00
  • Revenue This Year
  • ANVS N/A
  • MCHX N/A
  • Revenue Next Year
  • ANVS N/A
  • MCHX $4.63
  • P/E Ratio
  • ANVS N/A
  • MCHX N/A
  • Revenue Growth
  • ANVS N/A
  • MCHX N/A
  • 52 Week Low
  • ANVS $2.88
  • MCHX $1.11
  • 52 Week High
  • ANVS $20.00
  • MCHX $2.40
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 20.82
  • MCHX 46.43
  • Support Level
  • ANVS $2.99
  • MCHX $1.92
  • Resistance Level
  • ANVS $5.50
  • MCHX $2.06
  • Average True Range (ATR)
  • ANVS 0.34
  • MCHX 0.08
  • MACD
  • ANVS -0.18
  • MCHX 0.00
  • Stochastic Oscillator
  • ANVS 3.59
  • MCHX 53.57

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

Share on Social Networks: